What's new

Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 11, Status: Authorised

Mar 3, 2025 - 16:41
 0
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 11, Status: Authorised
Read More

Tags:

Previous Article

These Are The Cars You Should Replace Your Tesla With

Next Article

How to Buy SafeMoon: The Ultimate Guide to Buying SafeMoon Crypto on Trust Wallet

Related Posts

Industry Standing Group

Industry Standing Group

Feb 9, 2025  0

Patients' and Consumers' Working Party

Patients' and Consumers' Working Party

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Elucirem, Gadopiclenol, Date of authorisation: 07/12/2023, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0